BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 18282093)

  • 1. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.
    Couderc T; Chrétien F; Schilte C; Disson O; Brigitte M; Guivel-Benhassine F; Touret Y; Barau G; Cayet N; Schuffenecker I; Desprès P; Arenzana-Seisdedos F; Michault A; Albert ML; Lecuit M
    PLoS Pathog; 2008 Feb; 4(2):e29. PubMed ID: 18282093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation.
    Werneke SW; Schilte C; Rohatgi A; Monte KJ; Michault A; Arenzana-Seisdedos F; Vanlandingham DL; Higgs S; Fontanet A; Albert ML; Lenschow DJ
    PLoS Pathog; 2011 Oct; 7(10):e1002322. PubMed ID: 22028657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus.
    Rohatgi A; Corbo JC; Monte K; Higgs S; Vanlandingham DL; Kardon G; Lenschow DJ
    J Virol; 2014 Mar; 88(5):2414-25. PubMed ID: 24335291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
    Messaoudi I; Vomaske J; Totonchy T; Kreklywich CN; Haberthur K; Springgay L; Brien JD; Diamond MS; Defilippis VR; Streblow DN
    PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
    Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
    Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and therapy for Chikungunya virus infection.
    Couderc T; Khandoudi N; Grandadam M; Visse C; Gangneux N; Bagot S; Prost JF; Lecuit M
    J Infect Dis; 2009 Aug; 200(4):516-23. PubMed ID: 19572805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.
    Fros JJ; Liu WJ; Prow NA; Geertsema C; Ligtenberg M; Vanlandingham DL; Schnettler E; Vlak JM; Suhrbier A; Khromykh AA; Pijlman GP
    J Virol; 2010 Oct; 84(20):10877-87. PubMed ID: 20686047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
    Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
    J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.
    Rudd PA; Wilson J; Gardner J; Larcher T; Babarit C; Le TT; Anraku I; Kumagai Y; Loo YM; Gale M; Akira S; Khromykh AA; Suhrbier A
    J Virol; 2012 Sep; 86(18):9888-98. PubMed ID: 22761364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.
    Locke MC; Fox LE; Dunlap BF; Young AR; Monte K; Lenschow DJ
    J Virol; 2022 Jan; 96(1):e0114321. PubMed ID: 34668781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
    Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.
    Hawman DW; Stoermer KA; Montgomery SA; Pal P; Oko L; Diamond MS; Morrison TE
    J Virol; 2013 Dec; 87(24):13878-88. PubMed ID: 24131709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.
    Neupane B; Acharya D; Nazneen F; Gonzalez-Fernandez G; Flynt AS; Bai F
    Front Immunol; 2020; 11():588382. PubMed ID: 33304351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.
    Schilte C; Couderc T; Chretien F; Sourisseau M; Gangneux N; Guivel-Benhassine F; Kraxner A; Tschopp J; Higgs S; Michault A; Arenzana-Seisdedos F; Colonna M; Peduto L; Schwartz O; Lecuit M; Albert ML
    J Exp Med; 2010 Feb; 207(2):429-42. PubMed ID: 20123960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice.
    Teo TH; Lum FM; Claser C; Lulla V; Lulla A; Merits A; Rénia L; Ng LF
    J Immunol; 2013 Jan; 190(1):259-69. PubMed ID: 23209328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
    Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
    Issac TH; Tan EL; Chu JJ
    J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.